ACAD - Company ID 0001070494
ACADIA PHARMACEUTICALS INC has filed 1,357 public company documents between 2000 and 2026. The most frequent type is insider trade (615 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SC 13G/A | Passive ownership stake (update) | 10y ago2016-02-12 | - | View filing |
| SC 13G/A | Passive ownership stake (update) | 10y ago2016-02-11 | - | View filing |
| SC 13G | Passive ownership stake | 10y ago2016-02-10 | - | View filing |
| SC 13G/A | Passive ownership stake (update) | 10y ago2016-01-25 | - | View filing |
| 8-K | Major company event | 10y ago2016-01-12 | 2016-01-07 | View filing |
| 4 | Insider trade | 10y ago2016-01-11 | 2016-01-07 | View filing |
| 3 | New insider ownership | 10y ago2016-01-11 | 2016-01-07 | View filing |
| 4 | Insider trade | 10y ago2016-01-08 | 2016-01-07 | View filing |
| 4/A | Insider trade (amended) | 10y ago2016-01-08 | 2016-01-07 | View filing |
| SC 13D/A | Activist ownership stake (update) | 10y ago2016-01-08 | - | View filing |
| 8-K | Major company event | 10y ago2016-01-07 | 2016-01-06 | View filing |
| 424B5 | Prospectus supplement | 10y ago2016-01-07 | - | View filing |
| 424B5 | Prospectus supplement | 10y ago2016-01-05 | - | View filing |
| 8-K | Major company event | 10y ago2016-01-05 | 2016-01-05 | View filing |